Probiotics and prebiotics to combat enteric infections and HIV in the developing world: A consensus report

Gut Microbes

Volumn 2, Issue 3, 2011, Pages 198-207

  Monachese, Marc ^a   Cunningham Rundles, Susanna ^c   Diaz, Maria Alejandra ^d   Guerrant, Richard ^e   Hummelen, Ruben ^f   Kemperman, Rober ^g   Kerac, Marko ^h   Kort, Remco ⁱ   Merenstein, Dan ^j   Panigrahi, Pinaki ^k   Ramakrishna, Balakrishnan ^l   Safdar, Nasia ^m   Shane, Andi ⁿ   Trois, Livia ^o   Reid, Gregor ^a,b  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ VU UNIVERSITY AMSTERDAM   (Netherlands)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^k UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^l CHRISTIAN MEDICAL COLLEGE   (India)

^m UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o Department of Nutrition ^*  (Brazil)

more..

Author keywords

Diarrhea; HIV AIDS; Prebiotics; Probiotics; Resource disadvantaged; Roadmap

Indexed keywords

DEXTRAN DERIVATIVE; GALACTOSE OLIGOSACCHARIDE; GLUTAMINE; ORAL REHYDRATION SOLUTION; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RETINOL; SYNBIOTIC AGENT; ZINC;

ARTICLE; BACTERIAL STRAIN; DEVELOPING COUNTRY; DIARRHEA; DIET SUPPLEMENTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE INFECTION; MEDICAL RESEARCH; MICROFLORA; NONHUMAN; ORAL REHYDRATION THERAPY; PERMEABILITY BARRIER; QUALITY OF LIFE; VAGINITIS; CONFERENCE PAPER; FEMALE; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS; UTILIZATION REVIEW;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DIARRHEA; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; PREBIOTICS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85046980179     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.2.3.16106     Document Type: Article

References (83)

1. United Nations Development Programme. Human Development Index-2010; http://hdr.undp.org/en/statistics
2. WHO. Global Water Supply and Sanitation Assessment (2000) WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation, Geneva and New York 2001; http://www.who.int/docstore/water_sanitation_health/Globassessment/GlobalTOC.htm
3. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Child Health Epidemiology Reference Group of WHO and UNICEF*. Global, regional and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375:1969-87.
4. Ashbolt NJ. Microbial contamination of drinking water and disease outcomes in developing regions. Toxicology 2004; 198:229-38.
5. Walker CL, Friberg IK, Binkin N, Young M, Walker N, et al. Scaling up diarrhea prevention and treatment interventions: a lives saved tool analysis. PLoS Med 2011; 8:1000428.
6. Gibson GR, McCartney AL, Rastall RA. Prebiotics and resistance to gastrointestinal infections. Br J Nutr 2005; 93:31-4.
7. Sears CL. Molecular physiology and pathophysiology of tight junctions V. Assault of the tight junction by enteric pathogens. Am J Physiol Gastrointest Liver Physiol 2000; 279:1129-34.
8. Godwill OA, Kufa E, Ntabangana S, Alisalad A, Calleja JG. HIV/AIDS epidemiological surveillance report for the WHO African region: 2007 update; http://www.who.int/hiv/pub/surveillance/epi_afro2007/en/index.html
9. Sheehan LA, Macallan DC. Determinants of energy intake and energy expenditure in HIV and AIDS. Nutrition 2000; 16:101-6.
10. Arpadi MS. Growth failure in HIV-infected children, Consultation on nutrition and HIV/AIDS in Africa: evidence, lessons and recommendations for action. WHO, Department of Nutrition for Health and Development 2005; http://www.who.int/nutrition/topics/Paper%20Number%204%20-%20Growth%20failure.pdf
11. FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report 2001; http://www.fao.org/ag/agn/Probio/probio.htm
12. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52:988-97.
13. Thompson-Chagoyán OC, Maldonado J, Gil A. Aetiology of inflammatory bowel disease (IBD): Role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin Nutr 2005; 24:339-52.
14. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115-8.
15. Kaila M, Isolauri E, Soppi E, Virlanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr 1992; 32:141-4.
16. Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2001; 2:27-42.
17. Gill HS, Rutherford KJ, Prasad J, Gopal PK. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN107) and Bifidobacterium lactis (HN019). Br J Nutr 2000; 83:167-76.
18. Sinead CC, Yin L, Christian RU, Paul OW, Colin H, Cormac GMG. Bacteriocin production as a mechanism for the anti-infective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 2007; 104:7617-21.
19. Silva M, Jacobus VN, Deneke C, Gorbach LS. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31:1231-3.
20. Aiba Y, Suzuki N, Kabir AMA, Takagi A, Koda Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93:2097-101.
21. Carey CM, Kostrzynska M, Ojha S, Thompson S. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J Microbiol Methods 2008; 73:125-32.
22. Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, Takeda Y. Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7. Infect Immun 2004; 72:2240-7.
23. Li J, Wang W, Xu SX, Magarvey NA, McCormick JK. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc Natl Acad Sci USA 2011; 108:3360-5.
24. Bernet FM, Brassart D, Neeser RJ, Servin LA. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994; 35:483-9.
25. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-22.
26. Grandy G, Medina M, Soria R, Teran C, Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 2010; 10: 253.
27. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; 11:3048.
28. Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, Rojas Galarza RA. Probiotics for treating persistent diarrhoea in children. Cochrane Database of Syst Rev 2010; 11:7401.
29. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007; 335:335-40.
30. Guerrant RL, Oriá RB, Moore SR, Oriá MO, Lima AMA. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev 2008; 9:487-505.
31. Moore RS, Lima LN, Soares MA, Pinkerton FRJL, Guerrant LR, Lima AMA. Effects of prolonged episodes of acute diarrhea on childhood growth and risk of persistent diarrhea in northeast Brazil: A community birth cohort study. Gastroenterol 2010; 139: 156.
32. Guerrant DI, Moore SR, Lima AMA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhoea and Cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999; 61:707-13.
33. Generoso SV, Viana M, Santos R, Martins FS, Machado JA, Arantes RM, et al. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 2010; 192:477-84.
34. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci USA 2010; 107:454-9.
35. Hummelen R, Vos AP, van't Land B, van Norren K, Reid G. Altered host-microbe interaction in HIV: A target for intervention with pro- and prebiotics. Int Rev Immunol 2010; 29:485-513.
36. Anukam KC, Osazuwa OE, Osadolor BH, Bruce A, Reid G. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol 2008; 42:239-43.
37. Trois L, Cardoso ME, Miura E. Use of probiotics in HIV-infected children: A randomized double-blind controlled study. J Trop Pediatr 2008; 54:19-24.
38. Irvine LS, Hummelen R, Hekmat S, Looman C, Changalucha J, Habbema DF, et al. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol 2010; 44:201-5.
39. Cunningham-Rundles S, Lin H, Ho-Lin D, Dnistrian A, Cassileth BR, Perlman JM. Role of nutrients in the development of neonatal immune response. Nutr Rev 2009; 67:152-63.
40. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. Br J Nutr 201; 104:1-63.
41. Passariello A, Terrin G, De Marco G, Cecere G, Ruotolo S, Marino A, et al. Efficacy of a new hypotonic oral rehydration solution containing zinc and prebiotics in the treatment of childhood acute diarrhea: A randomized controlled trial. J Pediatr 2011; 158:288-292.
42. Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galactooligosaccharide mixture in reducing travellers' diarrhoea. Eur J Clin Nutr 2010; 64:146-52.
43. Panigrahi P, Parida S, Pradhan L, Mohapatra SS, Misra PR, Johnson JA, et al. Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut. J Pediatr Gastroenterol Nutr 2008; 47:45-53.
44. Kerac M, Bunn J, Seal A, Thindwa M, Tomkins A, Sadler K, et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi. Lancet 2009; 374:136-44.
45. Preidis GA, Hill C, Guerrant RL, Ramakrishna BS, Tannock GW, Versalovic J. Probiotics, enteric and diarrheal diseases and global health. Gastroenterology 2011;140:8-14.
46. Reid G, Gaudier E, Guarner F, Huffnagle BG, Macklaim J, Murcia Munoz A, et al. Responders and non-responders to probiotic interventions: how can we improve the odds? Gut Microbes 2010; 1:200-4.
47. Sur D, Manna B, Niyogi KS, Ramamurthy T, Palit A, Nomoto K, et al. Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiol Infect 2010; 1-8; DOI:10.1017/S0950268810001780.
48. Reid G. The potential role for probiotic yogurt for people living with HIV/AIDS. Gut Microbes 2010; 1:1-4.
49. Prahalad CK. In: Harris B, Ed. Fortune at the Bottom of the Pyramid. Strategy and Business issue 26. Uppersaddle River, NJ: Wharton School Publishing 2002.
50. Kort R, Sybesma W. Yoba for Life Foundation. http://www.yoba4life.com
51. Free C, Phillips G, Felix L, Galli L, Patel V, Edwards P. The effectiveness of M-health technologies for improving health and health services: a systematic review protocol. BMC Res Notes 2010; 3:250.
52. Odunfa SA. African fermented foods: from art to science. World J Microbiol Biotechnol 1988; 4:259-73.
53. Sazawal S, Dhingra U, Hiremath G, Sarkar A, Dhingra P, Dutta A, et al. Effects of Bifidobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia and growth among children 1 to 4 years old. J Pediatr Gastroenterol Nutr 2010; 51:341-6.
54. Chen P, Soares MA, Lima AA, Gamble VM, Schorling JB, Conway M, et al. Association of vitamin A and zinc status with altered intestinal permeability: analyses of cohort data from northeastern Brazil. J Health Popul Nutr 2003; 21:309-15.
55. Williams EA, Elia M, Lunn PG. A double-blind, placebo-controlled, glutamine-supplementation trial in growth-faltering Gambian infants. Am J Clin Nutr 2007; 86:421-7.
56. Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, et al. What works? Interventions for maternal and child under nutrition and survival. Lancet 2008; 371:417-40.
57. Niehaus MD, Moore SR, Patrick PD, Derr LL, Lorntz B, Lima AA, et al. Early childhood diarrhoea is associated with diminished cognitive function 4 to 7 years later in children in a northeast Brazilian shantytown. Am J Trop Med Hyg 2002; 66:590-3.
58. Victora CG, de Onis M, Hallal PC, Blossner M, Shrimpton R. Worldwide timing of growth failure: revisiting implications for interventions. Pediatrics 2010; 125:473-80.
59. Brignardello J, Morales P, Diaz E, Romero J, Brunser O, Gotteland M. Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther 2010; 32:1307-14.
60. Kelly P, Shawa T, Mwanamakondo S, Soko R, Smith G, Barclay GR, et al. Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomized controlled trial. BMC Gastroenterol 2010; 10:72.
61. Gladstone M, Lancaster GA, Umar E, Nyirenda M, Kayira E, van den Broek NR, et al. The Malawi Developmental Assessment Tool (MDAT): the creation, validation and reliability of a tool to assess child development in rural African settings. PLoS Med 2010; 7:1000273.
62. Mello RM, Morais MB, Tahan S, Melli LC, Rodrigues MS, Mello CS, et al. Lactobacilli and bifidobacteria in the feces of schoolchildren of two different socioeconomic groups: children from a favela and children from a private school. J Pediatr (Rio J) 2009; 85:307-14.
63. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 2010; 5:1-8.
64. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
65. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71.
66. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 2008; 295:1025-34.
67. Ancuta P, Monteiro P, Sekaly RP. Th17 lineage commitment and HIV-1 pathogenesis. Curr Opin HIV AIDS 2010; 5:158-65.
68. Yu Y, Sitaraman S, Gewirtz AT. Intestinal epithelial cell regulation of mucosal inflammation. Immunol Res 2004; 29:55-68.
69. Orne-Gliemann J, Mukotekwa T, Miller A, Perez F, Glenshaw M, Nesara P, et al. Community-based assessment of infant feeding practices within a programme for prevention of mother-to-child HIV transmission in rural Zimbabwe. Public Health Nutr 2006; 9:563-9.
70. Dicks LMT, Fraser T, Doeschate K, Van Reenen CA. Lactic acid bacteria population in children diagnosed with human immunodeficiency virus. J Paediatr Child Health 2009; 45:567-72.
71. Card CM, McLaren PJ, Wachihi C, Kimani J, Plummer AF, Fowke RK. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4+ CD25+ FOXP3+ regulatory T cells. J Infect Dis 2009; 199:1318-22.
72. Prendergast A, Prado GJ, Kang HY, Chen F, Riddell AL, Luzzi G, et al. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. AIDS 2010; 24:491-502.
73. Baroja ML, Kirjavainen PV, Hekmat S, Reid G. Antiinflammatory effects of probiotic-yogurt in inflammatory bowel disease patients. Clin Experimental Immunol 2007; 149:470-9.
74. Steenhout PG, Rochat F, Hager C. The Effect of Bifidobacterium lactis on the growth of infants: A pooled analysis of randomized controlled studies. Ann Nutr Metab 2009; 55:334-40.
75. Stewart AL, Hays RD, Ware JE Jr. The MOS shortform general health survey: reliability and validity in a patient population. Med Care 1988; 26:724-35.
76. Farmer P, Campos NG. Rethinking medical ethics: a view from below. Dev World Bioeth 2004; 4:17-41.
77. Brody BA. Ethical issues in clinical trials in developing countries. Stat Med 2002; 2:2853-8.
78. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 2007; 104:7617-21.
79. Botic T, Klingberg TD, Weingartl H, Cencic A. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol 2007; 115:227-34.
80. Conti C, Malacrino C, Mastromarino P. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 2009; 6:19-26.
81. Atkinson AJ Jr, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69:89-95.
82. Martin FP, Sprenger N, Montoliu I, Rezzi S, Kochhar S, Nicholson JK. Dietary modulation of gut functional ecology studied by fecal metabonomics. J Proteome Res 2010; 9:5284-95.
83. Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME et al. Impact of a symbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010; 10:4.